Zhejiang Gongdong Medical Technology Co Ltd
SSE:605369
Balance Sheet
Balance Sheet Decomposition
Zhejiang Gongdong Medical Technology Co Ltd
Current Assets | 876.7m |
Cash & Short-Term Investments | 497.8m |
Receivables | 252.4m |
Other Current Assets | 126.5m |
Non-Current Assets | 1B |
Long-Term Investments | 42.4m |
PP&E | 640.4m |
Intangibles | 307.1m |
Other Non-Current Assets | 11.7m |
Current Liabilities | 241.4m |
Accounts Payable | 78.1m |
Accrued Liabilities | 49.1m |
Other Current Liabilities | 114.2m |
Non-Current Liabilities | 20.2m |
Long-Term Debt | 268.7k |
Other Non-Current Liabilities | 20m |
Balance Sheet
Zhejiang Gongdong Medical Technology Co Ltd
Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | ||
---|---|---|---|---|---|---|---|
Assets | |||||||
Cash & Cash Equivalents |
88
|
186
|
115
|
773
|
708
|
703
|
|
Cash |
0
|
0
|
0
|
0
|
708
|
703
|
|
Cash Equivalents |
88
|
186
|
115
|
773
|
0
|
0
|
|
Short-Term Investments |
0
|
0
|
0
|
40
|
90
|
50
|
|
Total Receivables |
87
|
103
|
119
|
162
|
205
|
250
|
|
Accounts Receivables |
85
|
96
|
109
|
151
|
197
|
239
|
|
Other Receivables |
2
|
8
|
10
|
10
|
8
|
11
|
|
Inventory |
38
|
36
|
43
|
67
|
115
|
121
|
|
Other Current Assets |
1
|
2
|
5
|
5
|
14
|
10
|
|
Total Current Assets |
214
|
327
|
282
|
1 047
|
1 132
|
1 134
|
|
PP&E Net |
72
|
96
|
168
|
244
|
474
|
610
|
|
PP&E Gross |
72
|
96
|
168
|
244
|
474
|
610
|
|
Accumulated Depreciation |
73
|
82
|
94
|
90
|
88
|
127
|
|
Intangible Assets |
41
|
40
|
84
|
82
|
81
|
79
|
|
Note Receivable |
0
|
0
|
0
|
0
|
0
|
3
|
|
Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
37
|
|
Other Long-Term Assets |
1
|
1
|
1
|
2
|
3
|
4
|
|
Total Assets |
329
N/A
|
464
+41%
|
536
+15%
|
1 376
+157%
|
1 690
+23%
|
1 867
+11%
|
|
Liabilities | |||||||
Accounts Payable |
34
|
45
|
82
|
70
|
143
|
148
|
|
Accrued Liabilities |
17
|
19
|
22
|
40
|
48
|
62
|
|
Short-Term Debt |
10
|
40
|
0
|
0
|
0
|
0
|
|
Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
1
|
0
|
|
Other Current Liabilities |
14
|
17
|
24
|
54
|
99
|
53
|
|
Total Current Liabilities |
74
|
121
|
128
|
163
|
291
|
263
|
|
Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
Deferred Income Tax |
2
|
2
|
2
|
2
|
8
|
10
|
|
Other Liabilities |
0
|
0
|
1
|
3
|
2
|
2
|
|
Total Liabilities |
76
N/A
|
123
+61%
|
131
+6%
|
168
+28%
|
302
+80%
|
275
-9%
|
|
Equity | |||||||
Common Stock |
60
|
60
|
60
|
80
|
113
|
113
|
|
Retained Earnings |
30
|
115
|
179
|
404
|
571
|
742
|
|
Additional Paid In Capital |
163
|
166
|
166
|
724
|
735
|
756
|
|
Treasury Stock |
0
|
0
|
0
|
0
|
31
|
19
|
|
Other Equity |
0
|
1
|
1
|
0
|
0
|
1
|
|
Total Equity |
253
N/A
|
341
+35%
|
405
+19%
|
1 208
+198%
|
1 388
+15%
|
1 592
+15%
|
|
Total Liabilities & Equity |
329
N/A
|
464
+41%
|
536
+15%
|
1 376
+157%
|
1 690
+23%
|
1 867
+11%
|
|
Shares Outstanding | |||||||
Common Shares Outstanding |
84
|
84
|
84
|
112
|
112
|
112
|